![Emmett Cunningham](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Emmett Cunningham
No open positions remaining
Profile
Emmett T.
Cunningham is the founder of Ophthalmology Innovation Summit, founded in 2009, and Placid0, Inc., founded in 2020.
Dr. Cunningham is also the founder of Pr3vent, Inc,Visara, Inc. Dr. Cunningham is currently the Director-Uveitis Service at California Pacific Medical Center, Director at SFJ Pharmaceuticals, Inc., Director at Lumos Pharma Sub, Inc., Director at Viewpoint Therapeutics, Inc., Director at Silk Technologies Ltd., Adjunct Professor at Stanford University School of Medicine, Research Associate at UCSF School of Medicine, Research Associate at Francis I Proctor Foundation, and Senior Advisor at Healthquest Capital Management Co LLC.
Former positions include Director at NewLink Genetics Corp., Independent Director at Restoration Robotics, Inc. from 2011 to 2018, Director at Annexon, Inc. from 2014 to 2021, Director at Graybug Vision, Inc. from 2016 to 2020, Director at The University of California, San Francisco in 2001, Managing Director & Partner at Clarus Ventures LLC from 2017 to 2018, Senior Managing Director at Blackstone Life Sciences Advisors LLC, Independent Director at Lumos Pharma, Inc. from 2016 to 2021, Senior Managing Director at Blackstone, Inc. from 2018 to 2023, Independent Director at Galera Therapeutics, Inc. from 2018 to 2024, Director at SARcode Bioscience, Inc., Principal at Pfizer Inc., Senior Vice President-Medical Strategy at Oldtech, Inc. from 2001 to 2005, and Professor at New York University from 2002 to 2005.
Education includes a graduate degree and doctorate from The Johns Hopkins University, an undergraduate degree from Drexel University, and a doctorate from the University of California San Diego.
Latest news about Emmett Cunningham
Emmett Cunningham active positions
| Companies | Position | Start |
|---|---|---|
Viewpoint Therapeutics, Inc.
 Viewpoint Therapeutics, Inc. Provides drug discovery and development services for alpha-crystallin aggregation inhibitors as investigational non-surgical treatments | Director/Board Member | - |
SFJ Pharmaceuticals, Inc.
 SFJ Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops pharmaceuticals drugs | Director/Board Member | - |
Lumos Pharma Sub, Inc.
 Lumos Pharma Sub, Inc. Develops and commercializes a novel treatment for the rare disease Creatine Transporter Deficiency | Director/Board Member | - |
California Pacific Medical Center
 California Pacific Medical Center Miscellaneous Commercial ServicesCommercial Services Operates medical centers | Corporate Officer/Principal | - |
Francis I Proctor Foundation | Corporate Officer/Principal | - |
UCSF School of Medicine
 UCSF School of Medicine Functions as a College/University | Corporate Officer/Principal | - |
Stanford University School of Medicine
 Stanford University School of Medicine Functions as a College/University | Corporate Officer/Principal | 30/06/2008 |
Silk Technologies Ltd.
 Silk Technologies Ltd. Develops silk-derived protein (SDP) products for ophthalmic applications | Director/Board Member | - |
Healthquest Capital Management Co LLC
 Healthquest Capital Management Co LLC HealthQuest Capital invests in companies located in the United States. The firm focuses on the medical devices & technologies, diagnostics, healthcare IT, and innovative services. It provides financing for growth stage transactions with an investment size USD 20 to 100 million. It makes co-investments and also makes lead investment. | Private Equity Investor | 30/06/2023 |
Former positions of Emmett Cunningham
| Companies | Position | End |
|---|---|---|
| ░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░ ░░░░ | ░░░░░░░ ░░░░░░ ░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
Training of Emmett Cunningham
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 29 |
|---|---|
Pfizer Inc.
 Pfizer Inc. Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | |
NewLink Genetics Corp.
 NewLink Genetics Corp. Pharmaceuticals: MajorHealth Technology Discovers, develops, and commercializes novel immunotherapeutic products for treatment of cancer | Health Technology |
Oldtech, Inc.
 Oldtech, Inc. BiotechnologyHealth Technology Develops pharmaceutical products | Health Technology |
SARcode Bioscience, Inc.
 SARcode Bioscience, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products | Health Technology |
Restoration Robotics, Inc.
 Restoration Robotics, Inc. Medical SpecialtiesHealth Technology Manufactures medical devices for hair transplantation | Health Technology |
Annexon, Inc.
 Annexon, Inc. Develops novel therapeutics for neurodegenerative and autoimmune disorders | |
Graybug Vision, Inc.
 Graybug Vision, Inc. Operates as clinical-stage biopharmaceutical company, which focuses on developing transformative medicines for the treatment of chronic diseases of retina and optic nerve | |
Galera Therapeutics, Inc.
 Galera Therapeutics, Inc. Develops and commercializes drugs to reduce normal tissue toxicity from radiotherapy | |
California Pacific Medical Center
California Pacific Medical Center Miscellaneous Commercial ServicesCommercial Services Operates medical centers | Commercial Services |
Drexel University
 Drexel University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Johns Hopkins University
 The Johns Hopkins University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
New York University
 New York University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California San Diego
 University of California San Diego Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of California, San Francisco
 The University of California, San Francisco Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Clarus Ventures LLC
 Clarus Ventures LLC Investment ManagersFinance Clarus Ventures invests in companies located in the United States. The firm focuses on companies operating in the fields of biopharmaceutical and medical technology. It participates in early stage capital transactions. Clarus Ventures acquired by Blackstone Inc on November 30, 2018. Clarus ventures will become Blackstone Life Sciences. | Finance |
Blackstone, Inc.
 Blackstone, Inc. Investment ManagersFinance Provides investment and fund management services | Finance |
SFJ Pharmaceuticals, Inc.
SFJ Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops pharmaceuticals drugs | Health Technology |
Lumos Pharma Sub, Inc.
Lumos Pharma Sub, Inc. Develops and commercializes a novel treatment for the rare disease Creatine Transporter Deficiency | |
Stanford University School of Medicine
Stanford University School of Medicine Functions as a College/University | |
Healthquest Capital Management Co LLC
Healthquest Capital Management Co LLC HealthQuest Capital invests in companies located in the United States. The firm focuses on the medical devices & technologies, diagnostics, healthcare IT, and innovative services. It provides financing for growth stage transactions with an investment size USD 20 to 100 million. It makes co-investments and also makes lead investment. | |
UCSF School of Medicine
UCSF School of Medicine Functions as a College/University | |
Viewpoint Therapeutics, Inc.
Viewpoint Therapeutics, Inc. Provides drug discovery and development services for alpha-crystallin aggregation inhibitors as investigational non-surgical treatments | |
Silk Technologies Ltd.
Silk Technologies Ltd. Develops silk-derived protein (SDP) products for ophthalmic applications | |
Ophthalmology Innovation Summit
 Ophthalmology Innovation Summit Provides investment services | |
Pr3vent, Inc
 Pr3vent, Inc Provides healthcare technology services | |
Blackstone Life Sciences Advisors LLC
 Blackstone Life Sciences Advisors LLC Blackstone Life Sciences invests in companies located across the globe. The firm targets companies operating in the fields on pharmaceutical, biotechnology and medical technology sectors. It provides financing for growth stage transactions. | |
Lumos Pharma, Inc.
 Lumos Pharma, Inc. Operates as a clinical-stage biopharmaceutical company which engages in develops and markets therapeutics for rare diseases | |
Francis I Proctor Foundation | |
Placid0, Inc.
 Placid0, Inc. Develops mobile platform for assessing ocular conditions |
- Stock Market
- Insiders
- Emmett Cunningham
